NEW YORK, NY / ACCESSWIRE / October 7, 2021 / Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court the Southern District of New York, Case No. 1:21-cv-06051-KPF, on behalf of public common shareholders of Acasti Pharma, Inc. (“Acasti” or the “Company”) (NASDAQ:ACST) who held Acasti securities and were harmed by Acasti and its board of directors (the “Board”), alleging violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) in connection with the merger of Acasti with Grace Therapeutics, Inc. (“Grace”) (the “Transaction”).
Under the terms of the Transaction, Acasti acquired Grace, with former Acasti stockholders owning at least 55% and Grace stockholders owning at most 45% of the outstanding capital stock of the post-close combined company on a fully-diluted basis (the “Exchange Ratio”). The complaint alleges that the Merger Consideration was inadequate and that the Registration Statement on Form S-4 provided stockholders with materially incomplete and misleading information with the Securities and Exchange Commission, in violation of Sections 14(a) and 20(a) of the Exchange Act. The merger completed on August 27, 2021.
Mr. Juan Monteverde is available to personally discuss this case with you and if you wish to serve as lead plaintiff, you must move the Court no later than December 6, 2021. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice or may choose to do nothing and remain an absent class member.
Click here for more information: https://www.monteverdelaw.com/case/acasti-pharma-inc. It is free and there is no cost or obligation to you.
Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars for shareholders and is committed to protecting investors and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2020 Top Rated Lawyer. Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, over the years the firm has recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2021 Monteverde & Associates PC. Prior results do not guarantee a similar outcome with respect to any future matter.
SOURCE: Monteverde & Associates PC
View source version on accesswire.com:
https://www.accesswire.com/667207/Monteverde-Associates-PC-Filed-A-Class-Action-Lawsuit-On-Behalf-Of-Shareholders-Of-Acasti-Pharma-Inc-In-The-Southern-District-Of-New-York